Therapeutic efficacy and safety of photodynamic therapy in patients with central serous chorioretinopathy
Phase 1
- Conditions
- Central serous chorioretinopathy
- Registration Number
- JPRN-UMIN000025069
- Lead Sponsor
- Hyogo college of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
A patient with anaphylactic shock against verteporfin
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method